We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Sekisui Diagnostics

Download Mobile App




Excision Advised for Papillary Breast Lesions

By HospiMedica staff writers
Posted on 31 Mar 2006
A retrospective study recommends surgical excision of all papillary breast lesions, including benign ones, since diagnosis via core-needle breast biopsy alone was found to be inadequate.

Researchers at New York Presbyterian Hospital at Columbia University (New York, USA) and New York University Medical Center (New York, USA) retrospectively examined the imaging and histologic follow-up findings of 43 biopsies in 42 women who were diagnosed with papillary lesions from 1997-2003 at the two institutions. More...
After core-needle biopsies, 29 lesions were diagnosed as papilloma, eight as sclerosing papilloma, and six as benign papillary lesions not otherwise specified. Clinically, all lesions were nonpalpable, none of the patients had nipple discharge, and all 43 lesions were at least 2 cm from the nipple.

Of the 43 lesions, 36 were excised, and histologic examination showed that 26 were in fact benign. However, eight lesions were upgraded to papilloma with adjacent foci of atypical ductal hyperplasia, and another two to well-differentiated papillary ductal carcinoma in situ (DCIS). One woman had two tissue samples upgraded. In other words, 21.4% of the patients (nine of 42) actually had an atypical or malignant lesion. The results were reported in the March 2006 issue of Radiology.

All benign papillary lesions of the breast should be surgically excised, since a considerable number of atypical lesions and malignant lesions could be missed, said lead author Cecilia Mercado, M.D., of New York University Medical Center. In fact, she and her colleagues argue, the risk may be even greater than was shown because the study excluded women with nipple discharge or palpable masses.



Related Links:
New York Presbyterian Hospital
New York University Medical Center

Gold Member
Handheld Blood Glucose Analyzer
STAT-Site
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Glucose Meter
StatStrip®
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.